Megalac Hydrotalcit Chewable Tablets, 20 pcs

Instructions for use for Megalac Hydrotalcit Chewable Tablets, 20 pcs

Important notes (compulsory information):

Megalac HydrotalCit Chewable Tablets 500 mg. Active substance: Hydrotalkit. Areas of application: For the symptomatic treatment of diseases in which the gastric acid should be bound: stomach and duodenal ulcers; Sodburn and acid-related stomach complaints.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


Important notes (compulsory information):

Megalac HydrotalCit Chewable Tablets 500 mg. Areas of application: To treat symptoms of diseases in which gastric acid is to be bound: heartburn and acid-related stomach complaints, gastric or duodenum ulcers (Ulcus ventriculi or duodeni).

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Megalac HydrotalCit Chewable 500 mg
Active ingredient: hydrotalcite

Read the entire leaflet carefully before you start taking this medicine because it contains important information. Always take this medicine as described in this leaflet or just as your doctor or pharmacist is directed.

• Lift the package leaflet. You might want to read it again.
• Ask your pharmacist if you need more information or advice.
• If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. See section 4.
• If you do not feel better or even worse, contact your doctor.

What is in this leaflet:

1. What are Megalac Hydrotalcit chewable tablets and what are you used for?
2. What should you pay attention to chewable tablets before taking Megalac Hydrotalkit?
3. How are Megalac Hydrotalcit Chewable Tablets to take?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. How to keep Megalac Hydrotalcit chewable tablets?
6. Content of the pack and further information

1. What are Megalac Hydrotalcit chewable tablets and what are you used for?

MEGALAC HydrotalCit chewable tablets are a means for binding excess mammalic acid (antizidum). Megalac Hydrotalcit Chewable tablets are used to treat symptoms of diseases in which gastric acid is to be bound: heartburn and acid-related stomach complaints, gastric or duodenum ulcers (ulcer ventriculi or duodeni). When suspected of a gastric or duodenary ulcer, an investigation should be considered on H. pylori - and in the case of detection - a recognized antibacterial combination therapy, as the ulcer disease is generally uplifted in the event of successful application of such therapy.

2. What should you pay attention to chewable tablets before taking Megalac HydrotalCit?

MEGALAC HydrotalCit chewable tablets may not be taken if they are allergic to hydrotalcite, mint oil or one of the other ingredients of this medicine mentioned in section 6. MEGALAC HydrotalCit chewable tablets may only be used with renal function (creatinine clearance < 30 ml / min) with regular control of magnesium and aluminum serum levels. With reduced phosphate concentration in the blood (Hypophosphatemia) may take MEGALAC HydrotalCit chewable tablets only after consulting your doctor.

Children and adolescents under 12 years:
MEGALAC Hydrotalcit chewable tablets should not be applied to the treatment of children under 12 years, as there is no sufficient experience in this age group.

Warnings and Precautions:
Please talk to your doctor or pharmacist before taking Megalac Hydrotalcit chewable tablets. Long-lasting and recurring stomach complaints can be signs of a serious illness, e.g. A likesen- or duodenal ulcer. A treatment with Megalac Hydrotalkit chewable tablets should therefore take no longer than 14 days without a medical examination. If the teery chair occurs, blood petitions in the chair or vomiting of blood is immediately a doctor to visit. For long-term use of MEGALAC HydrotalCit chewable tablets, regular controls of the aluminum levels are required. 40 μg / L should not be exceeded. In patients with impaired renal function and chronic taking of high doses, there is a possibility of poisoning, such as an increase in magnesium mirror, increase in serum aluminum levels. With a long-term use of high doses and phosphatar diet, it can be used for phosphate hazard with the risk of bone softening (Osteomalazia) come. In patients with impaired renal function, therefore, a long-term intake of high doses should be avoided.

Taking Megalac Hydrotalcit Chewable Tablets together with other medicines:
Inform your doctor or pharmacist if you take / apply other medicines, recently taken / applied / applied or intend to take / use other medicines. The recording and thus the effectiveness of other medicines is reduced by megalac hydrotalcite chewing tablets. This is especially important for certain antibiotics (e.g., tetracyclines and quinolone derivatives such as ciprofloxacin, Ofloxacin and norfloxacin) and in drugs that increase the heart force (forced glycosides). Also, there is a possible influence on the solubility of medicines that are eliminated with the urine, e.g. Salicylate or quinidine to pay attention. Therefore, taking other medicines should take place 1 - 2 hours before or after taking Megalac HydrotalCit chewable tablets.




Taking Megalac Hydrotalcit Chewable Tablets together with food and beverages:
The simultaneous intake of Megalac Hydrotalcit chewable tablets with acid-contained drinks (fruit juices, wine) leads to an undesirable increase in aluminum absorption from the intestine. Effervescent tablets also contain fruit acids that can increase aluminum uptake.

Pregnancy and breast feeding period:
If you are pregnant or breastfeeding, or if you suspect to be pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy:
The benefit risk ratio should be carefully weighed carefully before taking hydrotalcit during pregnancy. The medicinal product should only be applied at short notice during pregnancy to avoid an aluminum burden of the child.

Latving:
Aluminum compounds go into breast milk. A risk for the newborn can not be assumed because only very small quantities are absorbed.

Driving and ability to operate machines:
There are no special features to consider.

Megalac HydrotalCit Chewable Tablets contain sorbitol and lactose:
Please take MEGALAC HydrotalCit chewable tablets only after consulting with your doctor if you are familiar with any intolerance to certain sugars.

3. How to take MEGALAC HydrotalCit chewable tablets?

Always take this medicine exactly as described in this leaflet or just according to the consultation made with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure. Unless otherwise prescribed by the doctor, the recommended dose is: If necessary, take 1 - 2 megalac hydrotalcit chewable tablets several times a day. The daily dose should not exceed 12 chewable tablets according to 6000 mg hydrotalcite. 1 chewing tablet contains 0.821 g of sorbitol (equivalent to 0.205 g of fructose). The calorie value is 2.6 kcal / g sorbitol. Note: In principle, taking other medicines should take place one to two hours before or after taking Megalac HydrotalCIT chewable tablets (see section 2. "Taking Megalac Hydrotalcit Chewable Tablets together with other medicines").

Type of application:
To take. Take Megalac Hydrotalcit chewable tablets between meals and sleeping with plenty of fluid (1 glass of water). If you get stomach-sensitiveh are, the intake should be done or after the meal. The chewable tablets should be well chewed and flushed down with a little liquid (see section 2. "Taking Megalac Hydrotalcit Chewable Tablets together with other medicines").

Duration of application:
The duration of the treatment depends on the nature and severity as well as the course of the disease. If the complaints remain under treatment for more than 2 weeks, a doctor should be visited. Please talk to your doctor or pharmacist if you have the impression that the effect of Megalac Hydrotalkit chewable tablets is too strong or too weak.

If you take a greater amount of Megalac Hydrotalkit chewable tablets than you should:
Poisoning with Megalac Hydrotalcit Chewable tablets are unlikely due to the low absorption of aluminum and magnesium. In the case of overdose, chassis behavior such as stool softening and increase in chair frequency can occur. Therapeutic measures are generally not required here.

If you forget to take Megalac Hydrotalcit chewable tablets:
Do not take the double amount when you forget the previous taking.

If you stop taking Megalac Hydrotalcit Chewable Tablets:
In any case, talk to your doctor before you - e.g. Due to the occurrence of side effects - unauthorized treatment with MEGALAC HydrotalCit chewable tablets interrupt or end prematurely.

If you have further questions about taking this medicine, contact your doctor or pharmacist.

4. Which side effects are possible?

Like all medicines, this medicine can also have side effects, but they do not have to occur each other.

The frequency information on side effects is based on the following categories:
Very often:	more than 1 treated from 10
Frequently:	1 to 10 treated from 100
Occasionally:	1 to 10 treated from 1 000
Rarely:	1 to 10 treated from 10 000
Very rare:	less than 1 treated from 10 000
Not known:	Frequency on the basis of the available data does not estimate.

Possible side effects:
Diseases of the gastrointestinal tract:
Very common: soft chairs.
Very rare: diarrhea.

Diseases of kidneys and urinary tract:
In severe renal function, the ingestion of magnesium and aluminum-containing drugs such as megalac hydrotalcite chewable tablets can be increased magnesium content of the blood (HyperMagnesemia) and cause serum aluminum mirrors. With insufficient renal performance (renal insufficiency) And with long-term taking of high doses, the aluminum storage can come primarily in the nerve and bone tissue and phosphate hazard.

Countermeasures with side effects:
Talk to your doctor if you get chewable tablets under treatment with Megalac Hydrotalkit. As a rule, a reduction of the dose will improve the complaints.

Message of side effects:
If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not indicated in this leaflet. You can also effectively effect the Federal Institute for Medicines and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger Allee 3, D-53175 Bonn, website: www.bfarm.de. By reporting side effects, you can help to provide more information about the security of this medicine.

5. How to keep Megalac Hydrotalcit chewable tablets?

Keep this medicine inaccessible to children. You may not use this medicine according to the expiry date specified on the carton and the throughput film according to "usable to:". The expiry date refers to the last day of the specified month.

Storage conditions:
Do not store more than 25 ° C.

6. Content of the pack and further information

What Megalac Hydrotalcit Caulet Tablets include:
The active ingredient is: hydrotalcite. 1 chewing tablet contains 500 mg hydrotalcite according to a neutralization capacity of mind. 13 Mval HCl. The other ingredients are: lactose monohydrate, hypromellosis, sorbitol (pH. EUR.), Calciumbenat (DAB), Peppermint flavor. 1 chewing tablet contains 0.821 g of sorbitol (equivalent to 0.205 g of fructose) according to approximately 0.07 bread units. The calorie value is 2.6 kcal / g sorbitol.

Like Megalac Hydrotalcit Chewable Appearance and Content of the Pack:
Megalac Hydrotalcit chewable tablets are white, round, on both sides flat tablets. Megalac HydrotalCit chewable tablets are packed with 20 chewable tablets (N1) and 50 chewable tablets (N2) available.

Pharmaceutical entrepreneur and manufacturer:
Krewel Meuselbach GmbH
Kreagelstraße 2
53783 Eitorf
Telephone: 02243 / 87-0
Fax: 02243 / 87-175
E-Mail: [email protected]

This information information was last revised in July 2013.

Source: Information of the leaflet
Status: 02/2017